サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574960

腹腔内感染症市場：診断別、用途別、治療別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Intra-Abdominal Infections Market, By Diagnosis, By Application, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
腹腔内感染症市場：診断別、用途別、治療別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

腹腔内感染症市場規模は2023年に225億9,043万米ドルとなり、2024年から2032年にかけてCAGR 8.90%で拡大

腹腔内感染症市場- 市場力学

抗生物質耐性の上昇が高度な治療オプションへの需要を促進

抗生物質耐性菌の増加により、腹腔内感染症に対するより良い治療法に対する需要が高まっています。標準的な抗生物質が効きにくくなるにつれ、ヘルスケアプロバイダーはこれらの感染症の管理に苦慮しています。米国疾病予防管理センター（CDC）の報告によると、米国では毎年300万件近くの抗生物質耐性感染症が発生しており、新しい治療法の緊急の必要性が浮き彫りになっています。この問題は患者の健康に影響を与えるだけでなく、ヘルスケア・システムにも大きな負担をかけています。

これに対し、研究者や製薬会社は新規抗生物質や代替療法を含む新たな解決策に取り組んでいます。その目標は、患者の予後を改善し、従来の方法では対処しきれなくなった感染症に取り組むために、これらの先進的な治療法を開発することです。この転換は、耐性菌が増加する中でより良いヘルスケアを確保するために極めて重要です。

腹腔内感染症市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.90%のCAGRで毎年成長すると推定されます。

治療別では、β-ラクタム薬が2023年に最大の市場シェアを示すと予測されました。

用途別では、腹腔内膿瘍が2023年の主要タイプでした。

診断別では、コンピュータ断層撮影（CT）が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

腹腔内感染症市場-セグメンテーション分析：

腹腔内感染症の世界市場は、診断、用途、治療、地域に基づいてセグメント化されます。

市場は治療別に3つのカテゴリーに分けられる：クロラムフェニコール系、βラクタム系、キノロン系、アミノグリコシド系。腹腔内感染症市場では、β-ラクタム系薬剤が主要な治療選択肢となっています。β-ラクタム系抗菌薬は、これらの感染症によくみられるグラム陽性菌とグラム陰性菌の両方を含む幅広い細菌を効果的に標的とするため、人気が高いです。

ペニシリンやセファロスポリンなどのβ-ラクタム系抗菌薬は、その有効性と安全性の高さから、しばしば治療の第一選択となります。βラクタム系抗菌薬は組織に浸透しやすいため、腹腔内細菌にも有効です。より多くの手術が実施され感染症が増加するにつれて、β-ラクタマーゼ製剤の需要は増加の一途をたどっており、この市場セグメントでトップの座を固めています。

市場は用途別に5つのカテゴリーに分類される：腹腔内膿瘍、虫垂炎、憩室炎、下痢、食中毒、ヘリコバクター・ピロリによる感染、その他です。腹腔内感染症市場では、腹腔内膿瘍が最も支配的なセグメントです。腹腔内膿瘍は臨床現場でよく見られ、虫垂炎や憩室炎などの合併症として発症することが多いです。腹腔内膿瘍は敗血症などの問題につながる可能性があり、迅速かつ効果的な治療が不可欠となります。これらの感染症を治療するための手術や抗生物質治療の必要性も、市場を後押ししています。

腹腔内感染症市場-地理的洞察

腹腔内感染症市場で最大の地域は北米です。この地域は病院数が多く、高度なヘルスケアシステムがこれらの感染症の診断と治療をサポートしています。外科手術の増加や肥満の蔓延が腹腔内感染症の増加につながっています。

また、大手ヘルスケア企業による新しい治療法の研究開発も盛んです。患者は抗生物質やその他の治療薬を利用できます。北米市場は、感染管理に対する意識の高まりといくつかの要因から成長が見込まれています。

腹腔内感染症市場-競合情勢：

腹腔内感染症市場には、これらの疾患に対する効果的な治療法の開発に注力する企業が複数存在します。メルク社は、さまざまな抗生物質と革新的な治療薬で市場をリードしています。ファイザーはさまざまな効果的治療薬を提供し、アストラゼネカはこの分野の研究で知られています。

アッヴィ社は感染症と闘うための標的治療に重点を置き、バイエル社は治療と支持療法をミックスしたものを提供しています。GSK（グラクソ・スミスクライン）も新薬の発見への投資に力を入れています。腹腔内感染症に対する認識が高まるにつれ、これらの企業は既存製品の改良と新治療法の導入にしのぎを削り、市場成長を牽引しています。

目次

第1章 腹腔内感染症市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 腹腔内感染症の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 腹腔内感染症に関する業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 腹腔内感染症市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 腹腔内感染症の市場情勢

  • 腹腔内感染症市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 腹腔内感染症市場- 診断別

  • 概要
    • 診断別セグメントシェア分析
    • 腹部X線
    • 血液検査
    • コンピュータ断層撮影（CT）
    • 超音波
    • その他

第8章 腹腔内感染症市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 腹腔内膿瘍
    • 虫垂炎
    • 憩室炎
    • 下痢
    • 食中毒
    • ヘリコバクター・ピロリによる感染
    • その他

第9章 腹腔内感染症市場-治療別

  • 概要
    • 治療別セグメントシェア分析
    • クロラムフェニコール
    • βラクタム
    • キノロン
    • アミノグリコシド
    • その他

第10章 腹腔内感染症市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 腹腔内感染症業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Merck &Co., Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Allergan（AbbVie）
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Johnson &Johnson
    • Basilea Pharmaceutica Ltd
    • Shionogi &Co., Ltd.
    • Achaogen, Inc.
    • Melinta Therapeutics, Inc.
    • Tetraphase Pharmaceuticals, Inc.
    • The Medicines Company
    • Dr. Reddy's Laboratories Ltd

第12章 アナリストの全方位展望

目次
Product Code: ANV4001

REPORT HIGHLIGHT

Intra-Abdominal Infections Market size was valued at USD 22,590.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The intra-abdominal infections market involves products and treatments for infections occurring inside the abdomen. These infections can affect organs like the stomach, intestines, and liver. They are often caused by bacteria and can lead to serious health issues if not treated promptly. The market includes antibiotics, surgical procedures, and medical devices used to manage these infections. With rising cases of obesity and other health conditions, the demand for effective treatments is growing. Overall, this market plays a crucial role in improving patient outcomes and healthcare quality.

Intra-Abdominal Infections Market- Market Dynamics

Rising antibiotic resistance fuels the demand for advanced treatment options.

Rising antibiotic resistance is increasing the demand for better treatments for intra-abdominal infections. As standard antibiotics become less effective, healthcare providers struggle to manage these infections. The Centres for Disease Control and Prevention (CDC) report that nearly 3 million antibiotic-resistant infections happen in the U.S. each year, highlighting the urgent need for new therapies. This issue not only affects patients' health but also puts a heavy strain on healthcare systems.

In response, researchers and pharmaceutical companies are working on new solutions, including novel antibiotics and alternative therapies. The goal is to develop these advanced treatments to improve patient outcomes and tackle infections that traditional methods can't manage anymore. This shift is crucial for ensuring better healthcare in the face of rising resistance.

Intra-Abdominal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Treatment segmentation, Beta-lactams was predicted to show maximum market share in the year 2023

Based on Application segmentation, Intra-Abdominal Abscesses was the leading type in 2023

Based on Diagnosis segmentation, Computed Tomography (CT) was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Intra-Abdominal Infections Market- Segmentation Analysis:

The Global Intra-Abdominal Infections Market is segmented based on Diagnosis, Application, Treatment, and Region.

The market is divided into three categories based on Treatment: Chloramphenicol, Beta Lactams, Quinolones, and Aminoglycosides. In the Intra-Abdominal Infections market, Beta-lactams are the leading treatment option. They are popular because they effectively target a wide range of bacteria, including both gram-positive and gram-negative types commonly associated with these infections.

Beta-lactams, such as penicillin and cephalosporins, are often the first choice for treatment due to their effectiveness and good safety record. They can also penetrate tissues easily, making them effective against intra-abdominal germs. As more surgeries are performed, leading to a rise in infections, the demand for Beta-lactamases continues to grow, reinforcing their top position in this market segment.

The market is divided into five categories based on Application: Intra-abdominal Abscess, Appendicitis, Diverticulitis, diarrhea, Food Poisoning, Infection by Helicobacter Pylori, and Others. In the Intra-Abdominal Infections market, the most dominant segment is Intra-Abdominal Abscesses. These are common in clinical settings and often occur as complications from conditions like appendicitis and diverticulitis. Intra-abdominal abscesses can lead to issues, such as sepsis, which makes quick and effective treatment essential. The need for surgery and antibiotic therapy to treat these infections also boost the market.

Intra-Abdominal Infections Market- Geographical Insights

The largest region in the Intra-Abdominal Infections market is North America. This area has a high number of hospitals and advanced healthcare systems, which support the diagnosis and treatment of these infections. The rise in surgical procedures and the increasing prevalence of obesity are leading to more intra-abdominal infections.

There is also strong research and development in new treatments, driven by major healthcare companies. Patients have access to antibiotics and other therapies. The North American market is expected to grow due to increasing awareness of infection management and several contributing factors.

Intra-Abdominal Infections Market- Competitive Landscape:

The intra-abdominal infections market features several players focused on developing effective treatments for these conditions. Merck & Co. leads with a range of antibiotics and innovative therapies. Pfizer Inc. offers a variety of effective medications, while AstraZeneca is known for its research in this field.

AbbVie Inc. focuses on targeted therapies to combat infections, and Bayer AG provides a mix of treatments and supportive care. GSK (GlaxoSmithKline) is also committed to investing in new drug discoveries. As awareness of intra-abdominal infections grows, these companies compete to improve existing products and introduce new therapies, driving market growth.

Recent Developments:

In January 2024, The NPPA reduced prices of antibiotics from Cipla and Wockhardt following their off-patent status, aiming to enhance accessibility and affordability for patients.

In January 2023, BDR Pharmaceuticals launched a new generic antibiotic, Ceftazidime + Avibactam, designed to combat gram-negative infections. This combination aims to enhance treatment options for challenging bacterial pathogens, addressing growing concerns over antibiotic resistance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Allergan (AbbVie)
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Basilea Pharmaceutica Ltd
  • Shionogi & Co., Ltd.
  • Achaogen, Inc.
  • Melinta Therapeutics, Inc.
  • Tetraphase Pharmaceuticals, Inc.
  • The Medicines Company
  • Dr. Reddy's Laboratories Ltd

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Abdominal X-ray
  • Blood Tests
  • Computed Tomography (CT)
  • Ultrasound

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Intra-abdominal Abscess
  • Appendicitis
  • Diverticulitis
  • Diarrhea
  • Food Poisoning
  • Infection by Helicobacter Pylori
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Chloramphenicol
  • Beta Lactams
  • Quinolones
  • Aminoglycosides
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intra-Abdominal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intra-Abdominal Infections Market Snippet by Diagnosis
    • 2.1.2. Intra-Abdominal Infections Market Snippet by Application
    • 2.1.3. Intra-Abdominal Infections Market Snippet by Treatment
    • 2.1.4. Intra-Abdominal Infections Market Snippet by Country
    • 2.1.5. Intra-Abdominal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Intra-Abdominal Infections Key Market Trends

  • 3.1. Intra-Abdominal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intra-Abdominal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intra-Abdominal Infections Market Opportunities
  • 3.4. Intra-Abdominal Infections Market Future Trends

4. Intra-Abdominal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intra-Abdominal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intra-Abdominal Infections Market Landscape

  • 6.1. Intra-Abdominal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intra-Abdominal Infections Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Abdominal X-ray
    • 7.1.3. Blood Tests
    • 7.1.4. Computed Tomography (CT)
    • 7.1.5. Ultrasound
    • 7.1.6. Others

8. Intra-Abdominal Infections Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Intra-abdominal Abscess
    • 8.1.3. Appendicitis
    • 8.1.4. Diverticulitis
    • 8.1.5. Diarrhoea
    • 8.1.6. Food Poisoning
    • 8.1.7. Infection by Helicobacter Pylori
    • 8.1.8. Others

9. Intra-Abdominal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Chloramphenicol
    • 9.1.3. Beta Lactams
    • 9.1.4. Quinolones
    • 9.1.5. Aminoglycosides
    • 9.1.6. Others

10. Intra-Abdominal Infections Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intra-Abdominal Infections Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intra-Abdominal Infections Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intra-Abdominal Infections Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Intra-Abdominal Infections Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Intra-Abdominal Infections Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intra-Abdominal Infections Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. AstraZeneca PLC
    • 11.2.4. Bayer AG
    • 11.2.5. Allergan (AbbVie)
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Eli Lilly and Company
    • 11.2.8. Sanofi S.A.
    • 11.2.9. F. Hoffmann-La Roche Ltd
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Basilea Pharmaceutica Ltd
    • 11.2.12. Shionogi & Co., Ltd.
    • 11.2.13. Achaogen, Inc.
    • 11.2.14. Melinta Therapeutics, Inc.
    • 11.2.15. Tetraphase Pharmaceuticals, Inc.
    • 11.2.16. The Medicines Company
    • 11.2.17. Dr. Reddy's Laboratories Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us